Charles River raises annual profit forecast on stabilizing biotech demand

Core Insights - Charles River Laboratories raised its annual profit forecast following strong third-quarter results, driven by stabilized demand in drug discovery and development services [1] Financial Performance - The company reported robust third-quarter results, indicating a positive trend in its financial performance [1] - The updated profit forecast reflects confidence in continued demand for its services [1] Market Demand - Stabilized demand for drug discovery and development services has contributed significantly to the company's performance [1]